Nicolaus Winters, MD
Pain Medicine · Evansville, INNPI 1750522660
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,265 of the $8,574 with a category attached, or 84.7%. Abbott accounts for 69.5% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2024 at $1,925 and has fallen 66.6% since, to $644 in 2025.
Across 349 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Amgen$624
- AbbVie$524
- Novartis$196
- Vertos Medical, Inc.$162
- Si-bone, Inc.$96
- plus $1K from 25 others
What the payments were for
- Consulting fees$1,23314%
- Food & beverage$7,26585%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 209 | $5,957 |
| Amgen(2 entities) | 42 | $624 |
| AbbVie(2 entities) | 26 | $524 |
| Novartis | 11 | $196 |
| Vertos Medical, Inc. | 4 | $162 |
| Si-bone, Inc. | 3 | $96 |
| Medtronic(2 entities) | 6 | $96 |
| Medical Device Business Services, Inc. | 1 | $90 |
| Tersera Therapeutics LLC | 4 | $81 |
| Pfizer | 6 | $80 |
| Protega Pharmaceutials Inc | 1 | $69 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Almatica Pharma LLC | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Boston Scientific | 3 | $44 |
| Stryker | 1 | $41 |
| Biohaven Pharmaceuticals, Inc. | 3 | $41 |
| Bioventus LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Nevro Corp. | 2 | $33 |
| Spinal Simplicity, LLC | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| AstraZeneca | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,233
- Proclaim Family of SCS IPGs$848
- mild Device Kit$107
How this compares
$8,574 in reported general payments places this provider in the 75th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,361 | $40,594 |
| BelbucaBuprenorphine Hcl | 43 | $24,264 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 900 | $19,542 |
| Buprenorphine | 61 | $18,966 |
| OxycontinOxycodone Hcl | 13 | $7,964 |
| Fentanyl | 40 | $6,141 |
| Gabapentin | 345 | $4,374 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 33 | $4,271 |
| AmantadineAmantadine Hcl | 27 | $3,600 |
| Oxycodone Hcl | 144 | $3,486 |
| Pregabalin | 155 | $3,318 |
| Morphine Sulfate ErMorphine Sulfate | 66 | $2,116 |
| Hydromorphone Hcl | 54 | $803 |
| Meloxicam | 25 | $684 |
| Morphine Sulfate | 24 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $35 | $24,26443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in Evansville
- Francis McDonnellEvansville$6K
- Joseph FolzEvansville$5K
- David JohnsonEvansville$4K
- Katherine WilliamsEvansville$4K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.